Clinical Trials Browser

Phase 2 × Brain Neoplasms × tislelizumab × Clear all

NCT04507217 2023-05-25

Tislelizumab Combined With Pemetrexed/ Carboplatin in Patients With Brain Metastases of Non-squamous NSCLC

Phase 2 Completed

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT05207904 2022-01-26

Tislelizumab Plus Chemotherapy as First-Line Treatment for Advanced Squamous NSCLC With Brain Metastases

Phase 2 Unknown

Brain Neoplasms